GOOD MORNING: The FDA is taking a scientific approach to evaluating direct-to-consumer (DTC) drug advertising, focusing on measuring consumer perceptions of the information presented in ads. Since when is consumer behavior ever scientific?
FDA and DTC
KEY TAKEAWAY: To suggest that ANY DTC ads are too distracting for fair balance information clearly shows just how out of touch the FDA is with the methods patients make healthcare decisions.